{"id":28736,"date":"2026-08-18T11:12:20","date_gmt":"2026-08-18T15:12:20","guid":{"rendered":"https:\/\/www.cryoport.com\/?p=28736"},"modified":"2026-08-18T11:17:17","modified_gmt":"2026-08-18T15:17:17","slug":"actualites-blog-au-dela-du-succes-clinique-bianca-gustafson-sur-la-mise-en-place-de-chaines-dapprovisionnement-evolutives","status":"publish","type":"post","link":"https:\/\/www.cryoport.com\/fr\/actualites-blog-au-dela-du-succes-clinique-bianca-gustafson-sur-la-mise-en-place-de-chaines-dapprovisionnement-evolutives\/","title":{"rendered":"Au-del\u00e0 de la r\u00e9ussite clinique : Bianca Gustafson nous parle de la mise en place de cha\u00eenes d’approvisionnement \u00e9volutives"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"

Dans un r\u00e9cent entretien accord\u00e9 \u00e0 Contract Pharma, Bianca Gustafson, directrice principale de la gestion des programmes chez Cryoport Systems, a apport\u00e9 un \u00e9clairage important sur la transition entre le d\u00e9veloppement clinique et la commercialisation. Selon Mme Gustafson, une erreur courante commise par les entreprises consiste \u00e0 consid\u00e9rer que la pr\u00e9paration \u00e0 la commercialisation n\u2019est qu\u2019un prolongement des op\u00e9rations cliniques, alors qu\u2019en r\u00e9alit\u00e9, la commercialisation n\u00e9cessite une refonte compl\u00e8te de la conception et de la mise \u00e0 l\u2019\u00e9chelle des cha\u00eenes d\u2019approvisionnement. <\/p>\n","protected":false},"author":38,"featured_media":28745,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"single-with-related.php","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[226],"tags":[624,481],"class_list":["post-28736","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articles-fr","tag-commercialisation","tag-gestion-de-la-chaine-dapprovisionnement"],"acf":[],"yoast_head":"\nAu-del\u00e0 de la r\u00e9ussite clinique : Bianca Gustafson nous parle de la mise en place de cha\u00eenes d'approvisionnement \u00e9volutives - Cryoport Systems<\/title>\n<meta name=\"description\" content=\"Dans une r\u00e9cente interview accord\u00e9e \u00e0 Contract Pharma, Bianca Gustafson, directrice principale de la gestion des programmes chez Cryoport Systems, a apport\u00e9 un \u00e9clairage important sur la transition entre le d\u00e9veloppement clinique et la commercialisation. Selon Mme Gustafson, une erreur courante commise par les entreprises consiste \u00e0 consid\u00e9rer que la pr\u00e9paration \u00e0 la commercialisation n\u2019est qu\u2019une prolongation des op\u00e9rations cliniques, alors qu\u2019en r\u00e9alit\u00e9, la commercialisation n\u00e9cessite une r\u00e9orientation compl\u00e8te de la conception et de la mise \u00e0 l\u2019\u00e9chelle des cha\u00eenes d\u2019approvisionnement.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cryoport.com\/fr\/actualites-blog-au-dela-du-succes-clinique-bianca-gustafson-sur-la-mise-en-place-de-chaines-dapprovisionnement-evolutives\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Au-del\u00e0 de la r\u00e9ussite clinique : Bianca Gustafson nous parle de la mise en place de cha\u00eenes d'approvisionnement \u00e9volutives - Cryoport Systems\" \/>\n<meta property=\"og:description\" content=\"Dans une r\u00e9cente interview accord\u00e9e \u00e0 Contract Pharma, Bianca Gustafson, directrice principale de la gestion des programmes chez Cryoport Systems, a apport\u00e9 un \u00e9clairage important sur la transition entre le d\u00e9veloppement clinique et la commercialisation. Selon Mme Gustafson, une erreur courante commise par les entreprises consiste \u00e0 consid\u00e9rer que la pr\u00e9paration \u00e0 la commercialisation n\u2019est qu\u2019une prolongation des op\u00e9rations cliniques, alors qu\u2019en r\u00e9alit\u00e9, la commercialisation n\u00e9cessite une r\u00e9orientation compl\u00e8te de la conception et de la mise \u00e0 l\u2019\u00e9chelle des cha\u00eenes d\u2019approvisionnement.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cryoport.com\/fr\/actualites-blog-au-dela-du-succes-clinique-bianca-gustafson-sur-la-mise-en-place-de-chaines-dapprovisionnement-evolutives\/\" \/>\n<meta property=\"og:site_name\" content=\"Cryoport Systems\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-18T15:12:20+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-18T15:17:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cryoport.com\/wp-content\/uploads\/2026\/08\/Contract-Pharma-QA-Bianca-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"628\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"smendez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@cryoport\" \/>\n<meta name=\"twitter:site\" content=\"@cryoport\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"smendez\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/actualites-blog-au-dela-du-succes-clinique-bianca-gustafson-sur-la-mise-en-place-de-chaines-dapprovisionnement-evolutives\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/actualites-blog-au-dela-du-succes-clinique-bianca-gustafson-sur-la-mise-en-place-de-chaines-dapprovisionnement-evolutives\\\/\"},\"author\":{\"name\":\"smendez\",\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/#\\\/schema\\\/person\\\/41e3344a83f354e30051a36b4e0a5f86\"},\"headline\":\"Au-del\u00e0 de la r\u00e9ussite clinique : Bianca Gustafson nous parle de la mise en place de cha\u00eenes d’approvisionnement \u00e9volutives\",\"datePublished\":\"2026-08-18T15:12:20+00:00\",\"dateModified\":\"2026-08-18T15:17:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/actualites-blog-au-dela-du-succes-clinique-bianca-gustafson-sur-la-mise-en-place-de-chaines-dapprovisionnement-evolutives\\\/\"},\"wordCount\":21,\"publisher\":{\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/actualites-blog-au-dela-du-succes-clinique-bianca-gustafson-sur-la-mise-en-place-de-chaines-dapprovisionnement-evolutives\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cryoport.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/Contract-Pharma-QA-Bianca-1.jpg\",\"keywords\":[\"Commercialisation\",\"Gestion de la cha\u00eene d'approvisionnement\"],\"articleSection\":[\"Articles\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/actualites-blog-au-dela-du-succes-clinique-bianca-gustafson-sur-la-mise-en-place-de-chaines-dapprovisionnement-evolutives\\\/\",\"url\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/actualites-blog-au-dela-du-succes-clinique-bianca-gustafson-sur-la-mise-en-place-de-chaines-dapprovisionnement-evolutives\\\/\",\"name\":\"Au-del\u00e0 de la r\u00e9ussite clinique : Bianca Gustafson nous parle de la mise en place de cha\u00eenes d'approvisionnement \u00e9volutives - Cryoport Systems\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/actualites-blog-au-dela-du-succes-clinique-bianca-gustafson-sur-la-mise-en-place-de-chaines-dapprovisionnement-evolutives\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/actualites-blog-au-dela-du-succes-clinique-bianca-gustafson-sur-la-mise-en-place-de-chaines-dapprovisionnement-evolutives\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cryoport.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/Contract-Pharma-QA-Bianca-1.jpg\",\"datePublished\":\"2026-08-18T15:12:20+00:00\",\"dateModified\":\"2026-08-18T15:17:17+00:00\",\"description\":\"Dans une r\u00e9cente interview accord\u00e9e \u00e0 Contract Pharma, Bianca Gustafson, directrice principale de la gestion des programmes chez Cryoport Systems, a apport\u00e9 un \u00e9clairage important sur la transition entre le d\u00e9veloppement clinique et la commercialisation. Selon Mme Gustafson, une erreur courante commise par les entreprises consiste \u00e0 consid\u00e9rer que la pr\u00e9paration \u00e0 la commercialisation n\u2019est qu\u2019une prolongation des op\u00e9rations cliniques, alors qu\u2019en r\u00e9alit\u00e9, la commercialisation n\u00e9cessite une r\u00e9orientation compl\u00e8te de la conception et de la mise \u00e0 l\u2019\u00e9chelle des cha\u00eenes d\u2019approvisionnement.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/actualites-blog-au-dela-du-succes-clinique-bianca-gustafson-sur-la-mise-en-place-de-chaines-dapprovisionnement-evolutives\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/actualites-blog-au-dela-du-succes-clinique-bianca-gustafson-sur-la-mise-en-place-de-chaines-dapprovisionnement-evolutives\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/actualites-blog-au-dela-du-succes-clinique-bianca-gustafson-sur-la-mise-en-place-de-chaines-dapprovisionnement-evolutives\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.cryoport.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/Contract-Pharma-QA-Bianca-1.jpg\",\"contentUrl\":\"https:\\\/\\\/www.cryoport.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/Contract-Pharma-QA-Bianca-1.jpg\",\"width\":1200,\"height\":628},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/actualites-blog-au-dela-du-succes-clinique-bianca-gustafson-sur-la-mise-en-place-de-chaines-dapprovisionnement-evolutives\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/homepage\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Au-del\u00e0 de la r\u00e9ussite clinique : Bianca Gustafson nous parle de la mise en place de cha\u00eenes d’approvisionnement \u00e9volutives\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/\",\"name\":\"Cryoport Systems\",\"description\":\"Enabling the Future of Medicine\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/#organization\",\"name\":\"Cryoport Systems\",\"url\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.cryoport.com\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/systems-square.png\",\"contentUrl\":\"https:\\\/\\\/www.cryoport.com\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/systems-square.png\",\"width\":1200,\"height\":1200,\"caption\":\"Cryoport Systems\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/cryoport\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/856887\",\"https:\\\/\\\/www.youtube.com\\\/user\\\/CryoportVideo\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/#\\\/schema\\\/person\\\/41e3344a83f354e30051a36b4e0a5f86\",\"name\":\"smendez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3ce9d56659c228959822d42e6e9146f3170fc590e93aa3adda9bb496df111835?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3ce9d56659c228959822d42e6e9146f3170fc590e93aa3adda9bb496df111835?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3ce9d56659c228959822d42e6e9146f3170fc590e93aa3adda9bb496df111835?s=96&d=mm&r=g\",\"caption\":\"smendez\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Au-del\u00e0 de la r\u00e9ussite clinique : Bianca Gustafson nous parle de la mise en place de cha\u00eenes d'approvisionnement \u00e9volutives - Cryoport Systems","description":"Dans une r\u00e9cente interview accord\u00e9e \u00e0 Contract Pharma, Bianca Gustafson, directrice principale de la gestion des programmes chez Cryoport Systems, a apport\u00e9 un \u00e9clairage important sur la transition entre le d\u00e9veloppement clinique et la commercialisation. Selon Mme Gustafson, une erreur courante commise par les entreprises consiste \u00e0 consid\u00e9rer que la pr\u00e9paration \u00e0 la commercialisation n\u2019est qu\u2019une prolongation des op\u00e9rations cliniques, alors qu\u2019en r\u00e9alit\u00e9, la commercialisation n\u00e9cessite une r\u00e9orientation compl\u00e8te de la conception et de la mise \u00e0 l\u2019\u00e9chelle des cha\u00eenes d\u2019approvisionnement.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cryoport.com\/fr\/actualites-blog-au-dela-du-succes-clinique-bianca-gustafson-sur-la-mise-en-place-de-chaines-dapprovisionnement-evolutives\/","og_locale":"fr_FR","og_type":"article","og_title":"Au-del\u00e0 de la r\u00e9ussite clinique : Bianca Gustafson nous parle de la mise en place de cha\u00eenes d'approvisionnement \u00e9volutives - Cryoport Systems","og_description":"Dans une r\u00e9cente interview accord\u00e9e \u00e0 Contract Pharma, Bianca Gustafson, directrice principale de la gestion des programmes chez Cryoport Systems, a apport\u00e9 un \u00e9clairage important sur la transition entre le d\u00e9veloppement clinique et la commercialisation. Selon Mme Gustafson, une erreur courante commise par les entreprises consiste \u00e0 consid\u00e9rer que la pr\u00e9paration \u00e0 la commercialisation n\u2019est qu\u2019une prolongation des op\u00e9rations cliniques, alors qu\u2019en r\u00e9alit\u00e9, la commercialisation n\u00e9cessite une r\u00e9orientation compl\u00e8te de la conception et de la mise \u00e0 l\u2019\u00e9chelle des cha\u00eenes d\u2019approvisionnement.","og_url":"https:\/\/www.cryoport.com\/fr\/actualites-blog-au-dela-du-succes-clinique-bianca-gustafson-sur-la-mise-en-place-de-chaines-dapprovisionnement-evolutives\/","og_site_name":"Cryoport Systems","article_published_time":"2026-08-18T15:12:20+00:00","article_modified_time":"2026-08-18T15:17:17+00:00","og_image":[{"width":1200,"height":628,"url":"https:\/\/www.cryoport.com\/wp-content\/uploads\/2026\/08\/Contract-Pharma-QA-Bianca-1.jpg","type":"image\/jpeg"}],"author":"smendez","twitter_card":"summary_large_image","twitter_creator":"@cryoport","twitter_site":"@cryoport","twitter_misc":{"\u00c9crit par":"smendez"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.cryoport.com\/fr\/actualites-blog-au-dela-du-succes-clinique-bianca-gustafson-sur-la-mise-en-place-de-chaines-dapprovisionnement-evolutives\/#article","isPartOf":{"@id":"https:\/\/www.cryoport.com\/fr\/actualites-blog-au-dela-du-succes-clinique-bianca-gustafson-sur-la-mise-en-place-de-chaines-dapprovisionnement-evolutives\/"},"author":{"name":"smendez","@id":"https:\/\/www.cryoport.com\/fr\/#\/schema\/person\/41e3344a83f354e30051a36b4e0a5f86"},"headline":"Au-del\u00e0 de la r\u00e9ussite clinique : Bianca Gustafson nous parle de la mise en place de cha\u00eenes d’approvisionnement \u00e9volutives","datePublished":"2026-08-18T15:12:20+00:00","dateModified":"2026-08-18T15:17:17+00:00","mainEntityOfPage":{"@id":"https:\/\/www.cryoport.com\/fr\/actualites-blog-au-dela-du-succes-clinique-bianca-gustafson-sur-la-mise-en-place-de-chaines-dapprovisionnement-evolutives\/"},"wordCount":21,"publisher":{"@id":"https:\/\/www.cryoport.com\/fr\/#organization"},"image":{"@id":"https:\/\/www.cryoport.com\/fr\/actualites-blog-au-dela-du-succes-clinique-bianca-gustafson-sur-la-mise-en-place-de-chaines-dapprovisionnement-evolutives\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cryoport.com\/wp-content\/uploads\/2026\/08\/Contract-Pharma-QA-Bianca-1.jpg","keywords":["Commercialisation","Gestion de la cha\u00eene d'approvisionnement"],"articleSection":["Articles"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.cryoport.com\/fr\/actualites-blog-au-dela-du-succes-clinique-bianca-gustafson-sur-la-mise-en-place-de-chaines-dapprovisionnement-evolutives\/","url":"https:\/\/www.cryoport.com\/fr\/actualites-blog-au-dela-du-succes-clinique-bianca-gustafson-sur-la-mise-en-place-de-chaines-dapprovisionnement-evolutives\/","name":"Au-del\u00e0 de la r\u00e9ussite clinique : Bianca Gustafson nous parle de la mise en place de cha\u00eenes d'approvisionnement \u00e9volutives - Cryoport Systems","isPartOf":{"@id":"https:\/\/www.cryoport.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cryoport.com\/fr\/actualites-blog-au-dela-du-succes-clinique-bianca-gustafson-sur-la-mise-en-place-de-chaines-dapprovisionnement-evolutives\/#primaryimage"},"image":{"@id":"https:\/\/www.cryoport.com\/fr\/actualites-blog-au-dela-du-succes-clinique-bianca-gustafson-sur-la-mise-en-place-de-chaines-dapprovisionnement-evolutives\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cryoport.com\/wp-content\/uploads\/2026\/08\/Contract-Pharma-QA-Bianca-1.jpg","datePublished":"2026-08-18T15:12:20+00:00","dateModified":"2026-08-18T15:17:17+00:00","description":"Dans une r\u00e9cente interview accord\u00e9e \u00e0 Contract Pharma, Bianca Gustafson, directrice principale de la gestion des programmes chez Cryoport Systems, a apport\u00e9 un \u00e9clairage important sur la transition entre le d\u00e9veloppement clinique et la commercialisation. Selon Mme Gustafson, une erreur courante commise par les entreprises consiste \u00e0 consid\u00e9rer que la pr\u00e9paration \u00e0 la commercialisation n\u2019est qu\u2019une prolongation des op\u00e9rations cliniques, alors qu\u2019en r\u00e9alit\u00e9, la commercialisation n\u00e9cessite une r\u00e9orientation compl\u00e8te de la conception et de la mise \u00e0 l\u2019\u00e9chelle des cha\u00eenes d\u2019approvisionnement.","breadcrumb":{"@id":"https:\/\/www.cryoport.com\/fr\/actualites-blog-au-dela-du-succes-clinique-bianca-gustafson-sur-la-mise-en-place-de-chaines-dapprovisionnement-evolutives\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cryoport.com\/fr\/actualites-blog-au-dela-du-succes-clinique-bianca-gustafson-sur-la-mise-en-place-de-chaines-dapprovisionnement-evolutives\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.cryoport.com\/fr\/actualites-blog-au-dela-du-succes-clinique-bianca-gustafson-sur-la-mise-en-place-de-chaines-dapprovisionnement-evolutives\/#primaryimage","url":"https:\/\/www.cryoport.com\/wp-content\/uploads\/2026\/08\/Contract-Pharma-QA-Bianca-1.jpg","contentUrl":"https:\/\/www.cryoport.com\/wp-content\/uploads\/2026\/08\/Contract-Pharma-QA-Bianca-1.jpg","width":1200,"height":628},{"@type":"BreadcrumbList","@id":"https:\/\/www.cryoport.com\/fr\/actualites-blog-au-dela-du-succes-clinique-bianca-gustafson-sur-la-mise-en-place-de-chaines-dapprovisionnement-evolutives\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cryoport.com\/fr\/homepage\/"},{"@type":"ListItem","position":2,"name":"Au-del\u00e0 de la r\u00e9ussite clinique : Bianca Gustafson nous parle de la mise en place de cha\u00eenes d’approvisionnement \u00e9volutives"}]},{"@type":"WebSite","@id":"https:\/\/www.cryoport.com\/fr\/#website","url":"https:\/\/www.cryoport.com\/fr\/","name":"Cryoport Systems","description":"Enabling the Future of Medicine","publisher":{"@id":"https:\/\/www.cryoport.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cryoport.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.cryoport.com\/fr\/#organization","name":"Cryoport Systems","url":"https:\/\/www.cryoport.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.cryoport.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.cryoport.com\/wp-content\/uploads\/2023\/12\/systems-square.png","contentUrl":"https:\/\/www.cryoport.com\/wp-content\/uploads\/2023\/12\/systems-square.png","width":1200,"height":1200,"caption":"Cryoport Systems"},"image":{"@id":"https:\/\/www.cryoport.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/cryoport","https:\/\/www.linkedin.com\/company\/856887","https:\/\/www.youtube.com\/user\/CryoportVideo"]},{"@type":"Person","@id":"https:\/\/www.cryoport.com\/fr\/#\/schema\/person\/41e3344a83f354e30051a36b4e0a5f86","name":"smendez","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/3ce9d56659c228959822d42e6e9146f3170fc590e93aa3adda9bb496df111835?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/3ce9d56659c228959822d42e6e9146f3170fc590e93aa3adda9bb496df111835?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/3ce9d56659c228959822d42e6e9146f3170fc590e93aa3adda9bb496df111835?s=96&d=mm&r=g","caption":"smendez"}}]}},"_links":{"self":[{"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/posts\/28736","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/users\/38"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/comments?post=28736"}],"version-history":[{"count":2,"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/posts\/28736\/revisions"}],"predecessor-version":[{"id":28753,"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/posts\/28736\/revisions\/28753"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/media\/28745"}],"wp:attachment":[{"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/media?parent=28736"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/categories?post=28736"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/tags?post=28736"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}